Physician profile
Robin N Kamal
NPI 1144422254
$343,096.18
in general payments reported to CMS, 2019-2025
13 companies · $65K in 2025
The $65K reported for 2025 was more than what 98% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $23K · 2021: $22K · 2022: $49K · 2023: $75K · 2024: $53K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $142K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $39K · Travel and Lodging: $8,759 · Food and Beverage: $4,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $141,985.65 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,962.50 |
| Travel and Lodging | $8,758.55 |
| Food and Beverage | $4,103.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $299,944.76 | 2019-2025 | Acumed, Acumed, Osteomed |
| Restor3d, INC. | $33,381.14 | 2021-2023 | |
| Trimed, INC. | $5,744.79 | 2021-2023 | |
| Axogen | $2,093.62 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Exsomed Corporation | $762.50 | 2019-2020 | |
| Skeletal Dynamics INC | $280.12 | 2021 | |
| Bioventus LLC | $237.15 | 2019-2020 | |
| Integra Lifesciences Corporation | $148.19 | 2022 | |
| Tenex Health INC. | $147.87 | 2021 | |
| Extremity Medical | $146.94 | 2022 | |
| Depuy Synthes Sales INC. | $125.64 | 2019 | |
| Trice Medical, INC. | $61.48 | 2021 | |
| Endo USA, INC. | $21.98 | 2025 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Kamal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.